Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial
Elias Jabbour, Federico Lussana, Pilar Martínez‐Sánchez, Anna Torrent, J. Rifón, Vaibhav Agrawal, Mar Tormo, Ryan D. Cassaday, Thomas Cluzeau, Françoise Huguet, Cristina Papayannidis, Jesús María Hernández‐Rivas, Anita W. Rijneveld, Shaun Fleming, Vladan Vučinić, Boris Böll, Takayuki Ikezoe, Maher Abdul‐Hay, Mary Lynn Savoie, Andre C. Schuh, Céline Berthon, Stefan Schwartz, Sabina Chiaretti, Junichiro Yuda, Takuya Miyazaki, José González‐Campos, Yuqi Chen, Hansen Wong, Jessica Choudhry, Gerhard Zugmaier, Erin Guest, Paul Gordon, Hagop M. Kantarjian
Topics & Concepts
MedicinePost-hoc analysisBlinatumomabRefractory (planetary science)Clinical trialInternal medicinePost hocOncologyPediatricsLymphoblastic LeukemiaLeukemiaAstrobiologyPhysicsAcute Lymphoblastic Leukemia researchLymphoma Diagnosis and TreatmentCAR-T cell therapy research